Tender detail

Conclusion of a non-exclusive rebate agreement for dydrogesterone-containing medicines

Summary

The tender concerns the conclusion of non-exclusive pharmaceutical rebate agreements for medicines containing dydrogesterone (ATC G03DB01). The agreements are intended to run from 1 October 2026 to 30 September 2028, with a possible 12-month extension, and may be concluded with all interested pharmaceutical companies that meet the requirements. The agreements will end automatically when an exclusive agreement for the same active substance enters into force.

Reference number
571940-2026
Buyer
DAK-Gesundheit
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-07-29
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
TED

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.